ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

AACI Adopts Plan To Step Up Cancer Issues Involvement

January 25, 1980

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

NCI Director Broder’s Year In Review: Avoid Politics, Stay Focused On Science

October 28, 1994

Manipulating The Therapeutic Index Clinical Trials Goal: Hellman

June 13, 1980